Perlegen Sciences has appointed Akira Usui as general manager of the company's new Perlegen Sciences Japan K.K. division. Usui has also been named vice president of Asia Business Development for Perlegen Sciences in the United States. He previously held a number of business-development and licensing positions with Tanabe Seiyaku and Roche Pharmaceuticals.
J. Robert Hurley has been named vice president for human resources and corporate communications at Beckman Coulter, effective May 23, the company said this week. Hurley is presently corporate vice president for restructuring at Baxter International, where he has worked since 1980.
Nobel laureate Paul Berg, professor emeritus of cancer research at Stanford University and director emeritus for the Beckman Center for Molecular and Genetic Medicine, will receive the Biotechnology Heritage award to be presented by the Chemical Heritage Foundation and the Biotechnology Industry Organization at BIO 2005 in Philadelphia, the organizations said last week. Berg, along with Walter Gilbert and Frederick Sanger, received the 1980 Nobel Prize in chemistry for developing methods that make it possible to map the structure and function of DNA.
Orchid BioSciences appointed Raymond Land as senior vice president and chief financial officer, effective June 6. Land succeeds Michael Spicer, who resigned in December 2004 to accept another position. From 1991 until 1996, Land served as senior vice president and chief financial officer of West Pharmaceutical Services. Land is currently serves a board member of Mountain View Pharmaceuticals.
Paul Gilman has been elected to the board of directors of JMAR Technologies, replacing Jack Martinez, who resigned April 22. Gilman was the founding director of the Oak Ridge Center for Advanced Studies, and before that position, served as assistant administrator for the Office of Research and Development at the Environmental Protection Agency, and as an EPA Science Advisor. Before working at the EPA, Gilman was director of Policy and Planning for Celera Genomics.